Changes in the expression of mitochondrial peroxiredoxin and thioredoxin in neurons and glia and their protective effects in experimental cerebral ischemic damage

Free Radical Biology and Medicine

Volumn 48, Issue 9, 2010, Pages 1242-1251

  Hwang, In Koo ^a   Yoo, Ki Yeon ^b   Kim, Dae Won ^b   Lee, Choong Hyun ^b   Choi, Jung Hoon ^b   Kwon, Young Guen ^c   Kim, Young Myeong ^d   Choi, Soo Young ^b   Won, Moo Ho ^b  

^a Seoul National University   (South Korea)

^b Hallym University   (South Korea)

^c Yonsei University   (South Korea)

^d Kangwon National University   (South Korea)

Author keywords

Astrocytes; Free radicals; Neuroprotection; Oxidative stress; Peroxiredoxin; Pyramidal neuron; Thioredoxin; Transient cerebral ischemia

Indexed keywords

CYTOCHROME C; OXIDOREDUCTASE; PEROXIREDOXIN 3; THIOREDOXIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTE; BRAIN ISCHEMIA; BRAIN MITOCHONDRION; CONTROLLED STUDY; CYTOPLASM; ENZYME RELEASE; GERBIL; HIPPOCAMPUS; LIPID PEROXIDATION; MALE; MICROGLIA; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL;

ANIMALS; BLOTTING, WESTERN; CA1 REGION, HIPPOCAMPAL; DISEASE MODELS, ANIMAL; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; GERBILLINAE; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; ISCHEMIC ATTACK, TRANSIENT; LIPID PEROXIDATION; MITOCHONDRIA; NEUROGLIA; PEROXIREDOXINS; PYRAMIDAL CELLS; THIOREDOXINS;

GERBILLINAE;

EID: 77950341411     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2010.02.007     Document Type: Article

References (45)

1. Eum W.S., Kim D.W., Hwang I.K., Yoo K.Y., Kang T.C., Jang S.H., Choi H.S., Choi S.H., Kim Y.H., Kim S.Y., Kwon H.Y., Kang J.H., Kwon O.S., Cho S.W., Lee K.S., Park J., Won M.H., Choi S.Y. In vivo protein transduction: biologically active intact pep-1-superoxide dismutase fusion protein efficiently protects against ischemic insult. Free Radic. Biol. Med. 2004, 37:1656-1669.
2. + exchanger 1 (NHE1) and neuroprotective effects of NHE inhibitor in the gerbil hippocampal CA1 region induced by transient ischemia. Exp. Neurol. 2008, 212:314-323.
3. Konaka K., Ueda H., Li J.Y., Matsumoto M., Sakoda S., Yanagihara T. N-acetylaspartate to total creatine ratio in the hippocampal CA1 sector after transient cerebral ischemia in gerbils: influence of neuronal elements, reactive gliosis, and tissue atrophy. J. Cereb. Blood Flow Metab. 2003, 23:700-708.
4. Manni M.L., Oury T.D. Commentary on "Copper chaperone for Cu,Zn-SOD supplement potentiates the Cu,Zn-SOD function of neuroprotective effects against ischemic neuronal damage in the gerbil hippocampus". Free Radic. Biol. Med. 2007, 43:899-900.
5. Fekete A., Vizi E.S., Kovács K.J., Lendvai B., Zelles T. Layer-specific differences in reactive oxygen species levels after oxygen-glucose deprivation in acute hippocampal slices. Free Radic. Biol. Med. 2008, 44:1010-1022.
6. Voloboueva L.A., Duan M., Ouyang Y., Emery J.F., Stoy C., Giffard R.G. Overexpression of mitochondrial Hsp70/Hsp75 protects astrocytes against ischemic injury in vitro. J. Cereb. Blood Flow Metab. 2008, 28:1009-1016.
7. Kim D.Y., Won S.J., Gwag B.J. Analysis of mitochondrial free radical generation in animal models of neuronal disease. Free Radic. Biol. Med. 2002, 33:715-723.
8. Xu L., Voloboueva L.A., Ouyang Y., Emery J.F., Giffard R.G. Overexpression of mitochondrial Hsp70/Hsp75 in rat brain protects mitochondria, reduces oxidative stress, and protects from focal ischemia. J. Cereb. Blood Flow Metab. 2009, 29:365-374.
9. Shigenaga M.K., Hagen T.M., Ames B.N. Oxidative damage and mitochondrial decay in aging. Proc. Natl. Acad. Sci. USA 1994, 91:10771-10778.
10. Endo H., Kamada H., Nito C., Nishi T., Chan P.H. Mitochondrial translocation of p53 mediates release of cytochrome c and hippocampal CA1 neuronal death after transient global cerebral ischemia in rats. J. Neurosci. 2006, 26:7974-7983.
11. Pond B.B., Galeffi F., Ahrens R., Schwartz-Bloom R.D. Chloride transport inhibitors influence recovery from oxygen-glucose deprivation-induced cellular injury in adult hippocampus. Neuropharmacology 2004, 47:253-262.
12. Kadenbach B., Arnold S., Lee I., Hüttemann M. The possible role of cytochrome c oxidase in stress-induced apoptosis and degenerative diseases. Biochim. Biophys. Acta 2004, 1655:400-408.
13. Kang S.W., Chae H.Z., Seo M.S., Kim K., Baines I.C., Rhee S.G. Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-α. J. Biol. Chem. 1998, 273:6297-6302.
14. Butterfield L.H., Merino A., Golub S.H., Shau H. From cytoprotection to tumor suppression: the multifactorial role of peroxiredoxins. Antioxid. Redox Signaling 1999, 1:385-402.
15. Fujii J., Ikeda Y. Advances in our understanding of peroxiredoxin, a multifunctional, mammalian redox protein. Redox Rep. 2002, 7:123-130.
16. Watabe S., Hiroi T., Yamamoto Y., Fujioka Y., Hasegawa H., Yago N., Takahashi S.Y. SP-22 is a thioredoxin-dependent peroxide reductase in mitochondria. Eur. J. Biochem. 1997, 249:52-60.
17. Wonsey D.R., Zeller K.L., Dang C.V. The c-Myc target gene PRDX3 is required for mitochondrial homeostasis and neoplastic transformation. Proc. Natl. Acad. Sci. USA 2002, 99:6649-6654.
18. Spyrou G., Enmark E., Miranda-Vizuete A., Gustafsson J.Å. Cloning and expression of a novel mammalian thioredoxin. J. Biol. Chem. 1997, 272:2936-2941.
19. Damdimopoulos A.E., Miranda-Vizuete A., Pelto-Huikko M., Gustafsson J.Å., Spyrou G. Human mitochondrial thioredoxin: involvement in mitochondrial membrane potential and cell death. J. Biol. Chem. 2002, 277:33249-33257.
20. Tanaka T., Hosoi F., Yamaguchi-Iwai Y., Nakamura H., Masutani H., Ueda S., Nishiyama A., Takeda S., Wada H., Spyrou G., Yodoi J. Thioredoxin-2 (TRX-2) is an essential gene regulating mitochondria-dependent apoptosis. EMBO J. 2002, 21:1695-1703.
21. A Stereotaxic Atlas of the Mongolian Gerbil Brain (Meriones unguiculatus) 1974, Ann Arbor Sci. Pub., Ann Arbor, MI. W.A. Loskota, P. Lomax, M.A. Verity (Eds.).
22. McKracken E., Graham D.I., Nilsen M., Stewart J., Nicoll J.A., Horsburgh K. 4-Hydroxynonenal immunoreactivity is increased in human hippocampus after global ischemia. Brain Pathol. 2001, 11:414-421.
23. Nakatsuka H., Ohta S., Tanaka J., Toku K., Kumon Y., Maeda N., Sakanaka M., Sakaki S. Release of cytochrome c from mitochondria to cytosol in hippocampal CA1 neurons after transient forebrain ischemia. Brain Res. 1999, 849:216-219.
24. Turner C., Schapira A.H. Mitochondrial dysfunction in neurodegenerative disorders and ageing. Adv. Exp. Med. Biol. 2001, 487:229-251.
25. Blomgren K., Zhu C., Hallin U., Hagberg H. Mitochondria and ischemic reperfusion damage in the adult and in the developing brain. Biochem. Biophys. Res. Commun. 2003, 304:551-559.
26. Bryk R., Griffin P., Nathan C. Peroxynitrite reductase activity of bacterial peroxiredoxins. Nature 2000, 407:211-215.
27. Cesaratto L., Vascotto C., D'Ambrosio C., Scaloni A., Baccarani U., Paron I., Damante G., Calligaris S., Quadrifoglio F., Tiribelli C., Tell G. Overoxidation of peroxiredoxins as an immediate and sensitive marker of oxidative stress in HepG2 cells and its application to the redox effects induced by ischemia/reperfusion in human liver. Free Radic. Res. 2005, 39:255-268.
28. Woo H.A., Chae H.Z., Hwang S.C., Yang K.S., Kang S.W., Kim K., Rhee S.G. Reversing the inactivation of peroxiredoxins caused by cysteine sulfinic acid formation. Science 2003, 300:653-656.
29. Woo H.A., Kang S.W., Kim H.K., Yang K.S., Chae H.Z., Rhee S.G. Reversible oxidation of the active site cysteine of peroxiredoxins to cysteine sulfinic acid: immunoblot detection with antibodies specific for the hyperoxidized cysteine-containing sequence. J. Biol. Chem. 2003, 278:47361-47364.
30. Kumar V., Kitaeff N., Hampton M.B., Cannell M.B., Winterbourn C.C. Reversible oxidation of mitochondrial peroxiredoxin 3 in mouse heart subjected to ischemia and reperfusion. FEBS Lett. 2009, 583:997-1000.
31. Chang T.S., Cho C.S., Park S., Yu S., Kang S.W., Rhee S.G. Peroxiredoxin III, a mitochondrion-specific peroxidase, regulates apoptotic signaling by mitochondria. J. Biol. Chem. 2004, 279:41975-41984.
32. Takagi Y., Horikawa F., Nozaki K., Sugino T., Hashimoto N., Yodoi J. Expression and distribution of redox regulatory protein, thioredoxin during transient focal brain ischemia in the rat. Neurosci. Lett. 1998, 251:25-28.
33. Takagi Y., Tokime T., Nozaki K., Gon Y., Kikuchi H., Yodoi J. Redox control of neuronal damage during brain ischemia after middle cerebral artery occlusion in the rat: immunohistochemical and hybridization studies of thioredoxin. J. Cereb. Blood Flow Metab. 1998, 18:206-214.
34. Katsuta K., Umemura K., Ueyama N., Matsuoka N. Pharmacological evidence for a correlation between hippocampal CA1 cell damage and hyperlocomotion following global cerebral ischemia in gerbils. Eur. J. Pharmacol 2003, 467:103-109.
35. Mileson B.E., Schwartz R.D. The use of locomotor activity as a behavioral screen for neuronal damage following transient forebrain ischemia in gerbils. Neurosci. Lett. 1991, 128:71-76.
36. Hattori F., Murayama N., Noshita T., Oikawa S. Mitochondrial peroxiredoxin-3 protects hippocampal neurons from excitotoxic injury in vivo. J. Neurochem. 2003, 86:860-868.
37. Takagi Y., Hattori I., Nozaki K., Mitsui A., Ishikawa M., Hashimoto N., Yodoi J. Excitotoxic hippocampal injury is attenuated in thioredoxin transgenic mice. J. Cereb. Blood Flow Metab. 2000, 20:829-833.
38. Sasada T., Iwata S., Sato N., Kitaoka Y., Hirota K., Nakamura K., Nishiyama A., Taniguchi Y., Takabayashi A., Yodoi J. Redox control of resistance to cis-diamminedichloroplatinum (II) (CDDP): protective effect of human thioredoxin against CDDP-induced cytotoxicity. J. Clin. Invest. 1996, 97:2268-2276.
39. Holmgren A. Thioredoxin. Annu. Rev. Biochem. 1985, 54:237-271.
40. Nonn L., Berggren M., Powis G. Increased expression of mitochondrial peroxiredoxin-3 (thioredoxin peroxidase-2) protects cancer cells against hypoxia and drug-induced hydrogen peroxide-dependent apoptosis. Mol. Cancer Res. 2003, 1:682-689.
41. Inomata Y., Nakamura H., Tanito M., Teratani A., Kawaji T., Kondo N., Yodoi J., Tanihara H. Thioredoxin inhibits NMDA-induced neurotoxicity in the rat retina. J. Neurochem. 2006, 98:372-385.
42. Shibuki H., Katai N., Yodoi J., Uchida K., Yoshimura N. Lipid peroxidation and peroxynitrite in retinal ischemia-reperfusion injury. Invest. Ophthalmol. Visual Sci. 2000, 41:3607-3614.
43. Jemmerson R., Liu J., Hausauer D., Lam K.P., Mondino A., Nelson R.D. A conformational change in cytochrome c of apoptotic and necrotic cells is detected by monoclonal antibody binding and mimicked by association of the native antigen with synthetic phospholipid vesicles. Biochemistry 1999, 38:3599-3609.
44. Nakatsuka H., Ohta S., Tanaka J., Toku K., Kumon Y., Maeda N., Sakanaka M., Sakaki S. Cytochrome c release from mitochondria to the cytosol was suppressed in the ischemia-tolerance-induced hippocampal CA1 region after 5-min forebrain ischemia in gerbils. Neurosci. Lett. 2000, 278:53-56.
45. Hetz C., Vitte P.A., Bombrun A., Rostovtseva T.K., Montessuit S., Hiver A., Schwarz M.K., Church D.J., Korsmeyer S.J., Martinou J.C., Antonsson B. Bax channel inhibitors prevent mitochondrion-mediated apoptosis and protect neurons in a model of global brain ischemia. J. Biol. Chem 2005, 280:42960-42970.